1 Shah PL, "The importance of complete screening for amyloid fibril type and systemic disease in patients with amyloidosis in the respiratory tract" 19 : 134-142, 2002
2 Wilson PG, "Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner" 173 : 1902-1910, 2008
3 Westermark GT, "Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis" 583 : 2685-2690, 2009
4 Anthony DC, "Robbins and Cotran pathologic basis of disease, professional edition" Saunders 1275-1276, 2008
5 "Nomenclature of amyloid and amyloidosis: WHO-IUIS Nomenclature Sub-Committee" 71 : 105-112, 1993
6 Conti-Fine BM, "Myasthenia gravis: past, present, and future" 116 : 2843-2854, 2006
7 Merlini G, "Molecular mechanisms of amyloidosis" 349 : 583-596, 2003
8 Ha SY, "Localized primary thymic amyloidosis presenting as a mediastinal mass: a case report" 45 : S41-S44, 2011
9 Siddachari RC, "Laryngeal amyloidosis" 34 : 60-63, 2005
10 Kaplan B, "Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease: high proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease" 144 : 705-715, 2009
1 Shah PL, "The importance of complete screening for amyloid fibril type and systemic disease in patients with amyloidosis in the respiratory tract" 19 : 134-142, 2002
2 Wilson PG, "Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner" 173 : 1902-1910, 2008
3 Westermark GT, "Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis" 583 : 2685-2690, 2009
4 Anthony DC, "Robbins and Cotran pathologic basis of disease, professional edition" Saunders 1275-1276, 2008
5 "Nomenclature of amyloid and amyloidosis: WHO-IUIS Nomenclature Sub-Committee" 71 : 105-112, 1993
6 Conti-Fine BM, "Myasthenia gravis: past, present, and future" 116 : 2843-2854, 2006
7 Merlini G, "Molecular mechanisms of amyloidosis" 349 : 583-596, 2003
8 Ha SY, "Localized primary thymic amyloidosis presenting as a mediastinal mass: a case report" 45 : S41-S44, 2011
9 Siddachari RC, "Laryngeal amyloidosis" 34 : 60-63, 2005
10 Kaplan B, "Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease: high proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease" 144 : 705-715, 2009
11 Bhat A, "Currents concepts on the immunopathology of amyloidosis" 38 : 97-106, 2010
12 Morgutti M, "Cellular immune response to acetylcholine receptor in myasthenia gravis: II. thymectomy and corticosteroids" 29 : 734-738, 1979
13 Urban BA, "CT evaluation of amyloidosis : spectrum of disease" 13 : 1295-1308, 1993
14 Hohlfeld R, "Autoimmune human T lymphocytes specific for acetylcholine receptor" 310 : 244-246, 1984
15 Wetmore JB, "Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patients" 13 : 593-600, 2008
16 Pepys MB, "Amyloidosis" 57 : 223-241, 2006
17 Takamori S, "Amyloid tumor in the anterior mediastinum: report of a case" 34 : 518-520, 2004